Medical Essentials — Operating Income (Loss)
Becton, Dickinson and Company Medical Essentials — Operating Income (Loss) increased by 517.2% to $574.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 49.9%, from $383.00M to $574.00M. Over 4 years (FY 2021 to FY 2026), Medical Essentials — Operating Income (Loss) shows a downward trend with a -5.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates improved profitability and operational efficiency, while a decrease signals margin pressure or declining segment performance.
Detailed definition
This metric represents the total operating profit or loss generated by the Medical Essentials segment after accounting f...
Peer comparison
Standard segment operating income metric used across all public companies with segment reporting.
bdx_segment_medical_essentials_operating_income_lossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $492.00M | $83.00M | $692.00M | $564.00M | $537.00M | $489.00M | $585.00M | $628.00M | $549.00M | $349.00M | $439.00M | $734.00M | $602.00M | $622.00M | $453.00M | $607.00M | $383.00M | $617.00M | $882.00M | $861.00M | $552.00M | $569.00M | $93.00M | $574.00M |
| QoQ Change | — | -83.1% | +733.7% | -18.5% | -4.8% | -8.9% | +19.6% | +7.4% | -12.6% | -36.4% | +25.8% | +67.2% | -18.0% | +3.3% | -27.2% | +34.0% | -36.9% | +61.1% | +42.9% | -2.4% | -35.9% | +3.1% | -83.7% | +517.2% |
| YoY Change | — | — | — | — | +9.1% | +489.2% | -15.5% | +11.3% | +2.2% | -28.6% | -25.0% | +16.9% | +9.7% | +78.2% | +3.2% | +38.3% | -47.8% | -15.9% | +46.5% | +38.4% | +21.9% | +25.6% | -75.7% | +49.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical essentials — operating income (loss)?
- Becton, Dickinson and Company (BDX) reported medical essentials — operating income (loss) of $574.00M in Q1 2026.
- How has Becton, Dickinson and Company's medical essentials — operating income (loss) changed year-over-year?
- Becton, Dickinson and Company's medical essentials — operating income (loss) increased by 49.9% year-over-year, from $383.00M to $574.00M.
- What is the long-term trend for Becton, Dickinson and Company's medical essentials — operating income (loss)?
- Over 4 years (2021 to 2026), Becton, Dickinson and Company's medical essentials — operating income (loss) has grown at a -5.6% compound annual growth rate (CAGR), from $2.25B to $1.79B.
- What does medical essentials — operating income (loss) mean?
- The total profit or loss generated by the Medical Essentials segment from its core operations.